Speech News and Research

RSS

NYU Langone receives $25 million to establish Fresco Institute for PD and movement disorders

NYU Langone Medical Center today announced that the Paolo and Marlene Fresco Foundation (Fresco Foundation) has generously given $25 million to establish the international Marlene and Paolo Fresco Institute for Parkinson's & Movement Disorders.

16 Jun 2015

'Brain-to-Text' system decodes spoken speech and transforms it into textual representation

Speech is produced in the human cerebral cortex. Brain waves associated with speech processes can be directly recorded with electrodes located on the surface of the cortex. It has now been shown for the first time that is possible to reconstruct basic units, words, and complete sentences of continuous speech from these brain waves and to generate the corresponding text.

16 Jun 2015

Novartis presents positive Phase III results of Farydak therapy at EHA

Novartis today presented results from a pivotal Phase III clinical trial exploratory subgroup analysis showing a 7.8-month improvement in median progression-free survival when using Farydak in combination with bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma who had received two or more prior regimens, including bortezomib and an immunomodulatory agent.

16 Jun 2015

Brain Injury Services of SWVA receives WWP grant to provide tele-health program for veterans with TBI

Brain Injury Services of SWVA has received a grant from Wounded Warrior Project (WWP) to provide a unique tele-health program, the Community Living Connection (CLiC) for veterans with traumatic brain injury (TBI), to overcome the diverse challenges of the complex condition. WWP's Grant Program, now in its fourth year, is expanding the availability of programs and services that provide support to this generation of injured service members.

11 Jun 2015

UT Southwestern researchers reveal how the body controls glucose transport

UT Southwestern Medical Center scientists have gleaned a key cellular mechanism of how the body adjusts glucose levels, an important process that when abnormal can promote diabetes, cancer, and rare genetic diseases.

10 Jun 2015

NYU Langone Medical Center celebrates 65th anniversary of Rusk Rehabilitation

Howard A. Rusk, MD (1901-1989), a tall, soft-spoken physician from NYU Langone Medical Center and widely considered "the father of rehabilitation medicine," set about to establish a facility founded on the belief that care should focus on the whole person—not just on their physical illness or disability, but also on their emotional, psychological, and social needs as well.

10 Jun 2015

Manchester first to implement Congenica's Sapientia technology to provide fast, accurate diagnosis for genetic diseases

10,000 new patients a year are treated by the Manchester Centre for Genomic Medicine (MCGM) for a range of rare diseases including cancers, developmental disorders and disabilities including hearing and vision loss - diagnosis can be time-consuming and invasive.

10 Jun 2015

Early intervention helps improve intellectual ability, reduces autism symptoms in children

Early intervention for toddlers with autism spectrum disorder helps improve their intellectual ability and reduces autism symptoms years after originally getting treatment, a new study shows.

9 Jun 2015

New UF study shows that multi-tasking may improve cognitive performance

A new University of Florida study challenges the notion that multi-tasking causes one or both activities to suffer. In a study of older adults who completed cognitive tasks while cycling on a stationary bike, UF researchers found that participants' cycling speed improved while multi-tasking with no cost to their cognitive performance.

3 Jun 2015

Fennec presents positive interim results from phase III trial of sodium thiosulphate at ASCO 2015

Fennec Pharmaceuticals, Inc., announced the presentation of positive interim results from a poster presented today entitled, "Anti-tumor efficacy in SIOPEL6: A multi-centre open label randomised phase III trial of the efficacy of sodium thiosulphate (STS) in reducing ototoxicity in patients receiving cisplatin (Cis) monotherapy for standard risk hepatoblastoma (SR-HB)."

2 Jun 2015

Genesis Rehab Services forms groundbreaking partnership with Zhejiang Bang-Er Medical Group

Genesis Rehab Services, a division of Genesis HealthCare, one of the nation's largest providers of post-acute care, today announced a groundbreaking partnership with Zhejiang Bang-Er Medical Group, an orthopedic hospital system in China.

2 Jun 2015

Upsher-Smith announces FDA approval of sNDA for Qudexy XR extended-release capsules

Upsher-Smith Laboratories, Inc. announced that it has received U.S. Food and Drug Administration approval of a supplemental new drug application (sNDA) for Qudexy XR (topiramate) extended-release capsules for use as initial monotherapy in patients two years of age and older who are experiencing partial-onset seizures (POS) or primary generalized tonic-clonic seizures.

2 Jun 2015

Modified poliovirus therapy for glioblastoma works best at a low dosage

A modified poliovirus therapy that is showing promising results for patients with glioblastoma brain tumors works best at a low dosage, according to the research team at Duke's Preston Robert Tisch Brain Tumor Center where the investigational therapy is being pioneered.

1 Jun 2015

CHOP Global Health Center performs first rigorous study of CP outcomes in Africa

Cerebral palsy (CP) is the most common cause of childhood disability in the world, affecting between 1 and 2 infants per thousand. But the neurological condition tends to be understudied, especially in developing countries.

29 May 2015

Autism and apraxia often go hand-in-hand

Some children with autism should undergo ongoing screenings for apraxia, a rare neurological speech disorder, because the two conditions often go hand-in-hand, according to Penn State College of Medicine researchers.

28 May 2015

Amgen to present clinical data on multiple blood cancer treatments at EHA 2015

Amgen today announced that it will present data from multiple Kyprolis (carfilzomib) for Injection, BLINCYTO (blinatumomab), oprozomib and Nplate (romiplostim)‎ studies at the 20th Congress of the European Hematology Association taking place in Vienna, June 11 - 14, 2015.

28 May 2015

UC San Diego Health System designated as Center of Excellence for Huntington's disease

The Huntington's Disease Clinical Research Center at UC San Diego Health System has been designated a Center of Excellence by the Huntington's Disease Society of America. UC San Diego was one of only 29 centers nationwide to receive this prestigious designation, which recognizes centers for their elite multidisciplinary approach to Huntington's disease care and research.

27 May 2015

Racial stereotypes can impact the way we communicate, understand others

Racial stereotypes and expectations can impact the way we communicate and understand others, according to UBC research. The new study, published in the Journal of the Acoustical Society of America, highlights how non-verbal "social cues" - such as photographs of Chinese Canadians - can affect how we comprehend speech.

27 May 2015

New investments may enable two Canadian organizations to improve life for people with hearing loss

New investments from public and private sources in Canada and the USA, including Grand Challenges Canada and Google.org, will enable two Canadian organizations to contribute to a better life for people with hearing loss in developing countries.

27 May 2015

Essential fatty acids play crucial role in human brain growth and function

New research conducted in a rural community in Pakistan highlights the crucial role that essential fatty acids play in human brain growth and function.

26 May 2015

Speech News and Research

NYU Langone receives $25 million to establish Fresco Institute for PD and movement disorders

'Brain-to-Text' system decodes spoken speech and transforms it into textual representation

Novartis presents positive Phase III results of Farydak therapy at EHA

Brain Injury Services of SWVA receives WWP grant to provide tele-health program for veterans with TBI

UT Southwestern researchers reveal how the body controls glucose transport

NYU Langone Medical Center celebrates 65th anniversary of Rusk Rehabilitation

Manchester first to implement Congenica's Sapientia technology to provide fast, accurate diagnosis for genetic diseases

Early intervention helps improve intellectual ability, reduces autism symptoms in children

New UF study shows that multi-tasking may improve cognitive performance

Fennec presents positive interim results from phase III trial of sodium thiosulphate at ASCO 2015

Genesis Rehab Services forms groundbreaking partnership with Zhejiang Bang-Er Medical Group

Upsher-Smith announces FDA approval of sNDA for Qudexy XR extended-release capsules

Modified poliovirus therapy for glioblastoma works best at a low dosage

CHOP Global Health Center performs first rigorous study of CP outcomes in Africa

Autism and apraxia often go hand-in-hand

Amgen to present clinical data on multiple blood cancer treatments at EHA 2015

UC San Diego Health System designated as Center of Excellence for Huntington's disease

Racial stereotypes can impact the way we communicate, understand others

New investments may enable two Canadian organizations to improve life for people with hearing loss

Essential fatty acids play crucial role in human brain growth and function

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News